| Literature DB >> 32765033 |
Na Yang1, Liyun He1, Yuxiu Li1, Lingling Xu1, Fan Ping1, Wei Li1, Huabing Zhang1.
Abstract
PURPOSE: High dietary magnesium intake may reduce insulin resistance (IR) and metabolic syndrome (MetS). The aim of the cross-sectional analysis was to evaluate the association between dietary magnesium intake, IR, and MetS using data from China Health and Nutrition Survey.Entities:
Keywords: Chinese population; diet magnesium intake; insulin resistance; mediation effect; metabolic syndrome
Year: 2020 PMID: 32765033 PMCID: PMC7373413 DOI: 10.2147/DMSO.S257884
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Figure 1Study flow diagram.
Abbreviation: CHNS, the China Health and Nutrition Survey.
Baseline Characteristics of the Study Population According to Quartiles of Dietary Magnesium Intake per Kilogram Body Weight
| Magnesium Intake/kg (Quartiles) | |||||
|---|---|---|---|---|---|
| 1 (Low) | 2 | 3 | 4 (High) | P* | |
| Age (years) | 52.77±15.72 | 50.82±14.71 | 50.03±14.77 | 50.55±14.71 | <0.001 |
| Male (%) | 45.1 | 46.0 | 47.9 | 49.3 | 0.034 |
| BMI (kg/m2) | 24.99±3.64 | 23.85±3.27 | 22.69±2.96 | 21.83±2.98 | <0.001 |
| Daily dietary intake | |||||
| Mg intake/kg (mg/kg) | 2.91±0.52 | 4.09±0.28 | 5.14±0.36 | 7.66±2.06 | <0.001 |
| Mg intake (mg) | 190.61±46.16 | 254.04±45.52 | 301.93±52.99 | 426.05±124.43 | <0.001 |
| Energy intake (kcal) | 1617.65±459.49 | 1935.12±472.97 | 2166.51±520.13 | 2600.07±587.39 | <0.001 |
| Protein intake (kcal) | 49.28±15.32 | 60.83±16.55 | 68.82±17.77 | 85.23±24.93 | <0.001 |
| Fat intake (kcal) | 59.69±31.52 | 65.32±31.00 | 70.40±33.67 | 79.08±34.82 | <0.001 |
| Carbohydrate intake (kcal) | 220.53±67.15 | 273.96±76.31 | 312.07±87.76 | 387.14±105.77 | <0.001 |
| Urban residence (%) | 37.6 | 36.5 | 32.3 | 25.7 | <0.001 |
| High school education or above (%) | 27.0 | 25.6 | 24.1 | 18.0 | <0.001 |
| Current drinker (%) | 30.2 | 32.2 | 34.4 | 35.2 | 0.020 |
| Ever smoked (%) | 29.1 | 29.6 | 31.4 | 34.4 | 0.003 |
| HOMA-IR | 4.56±8.61 | 3.93±7.37 | 3.50±6.12 | 3.11±6.20 | <0.001 |
| FINS (uIU/mL) | 16.50±24.75 | 14.70±20.80 | 13.92±24.15 | 12.49±19.62 | <0.001 |
| FBG (mmol/L) | 5.69±1.73 | 5.44±1.47 | 5.33±1.32 | 5.20±1.18 | <0.001 |
| WC (cm) | 86.73±10.28 | 83.66±10.00 | 80.73±9.47 | 79.36±9.59 | <0.001 |
| SBP (mmHg) | 128.49±20.39 | 125.49±18.52 | 123.77±18.66 | 122.12±17.96 | <0.001 |
| DBP (mmHg) | 82.30±11.61 | 80.95±11.07 | 80.01±11.44 | 79.14±11.35 | <0.001 |
| TC (mmol/L) | 5.04±1.04 | 4.91±1.00 | 4.77±0.98 | 4.73±0.95 | <0.001 |
| TG (mmol/L) | 1.87±1.51 | 1.79±1.72 | 1.61±1.41 | 1.45±1.27 | <0.001 |
| LDL (mmol/L) | 3.13±0.99 | 3.01±0.99 | 2.90±0.92 | 2.88±0.99 | <0.001 |
| HDL (mmol/L) | 1.38±0.41 | 1.41±0.42 | 1.46±0.65 | 1.50±0.46 | <0.001 |
Notes: Data are presented as means±SD, or %. *P values are for any difference across the quartiles of magnesium intake using ANOVA or χ2 test as appropriate. Mg intake/kg: dietary magnesium intake per kilogram body weight, Mg intake: dietary magnesium intake.
Abbreviations: BMI, body mass index; FINS, fasting insulin; FBG, fast blood glucose; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.
Prevalence Ratios (95% CI) for Insulin Resistance According to Quartiles of Dietary Magnesium Intake per Kilogram Body Weight
| Magnesium Intake/kg (Quartiles) | |||||
|---|---|---|---|---|---|
| 1 (Low) | 2 | 3 | 4 (High) | P* | |
| 1 | 0.690(0.604, 0.790) | 0.553(0.481, 0.635) | 0.435(0.376, 0.502) | <0.001 | |
| Model 1 | 1 | 0.651(0.567, 0.748) | 0.496(0.426, 0.576) | 0.347(0.290, 0.416) | <0.001 |
| Model 2 | 1 | 0.646(0.563, 0.743) | 0.493(0.424, 0.573) | 0.347 (0.289, 0.415) | <0.001 |
| Model 3 | 1 | 0.589(0.511, 0.678) | 0.421(0.360, 0.493) | 0.250(0.204, 0.306) | <0.001 |
Notes: Data are presented as coefficients (95% CI). Insulin resistance was defined by the upper quartile of HOMA-IR. *All models were constructed using the logistic regression analysis. Model 1: adjustment for total energy intake (kcal/day), age (years) and male (yes or no); model 2: model 1 with additional adjustment for ever smoking (yes or no), current alcohol consumption (yes or no), education level (high school degree or above, degree below high school), and residence (urban or not urban); model 3: model 2 with additional adjustment total energy intake (kcal/day), total protein intake (g/day), total carbohydrate intake (g/day), and total fat intake (g/day). Magnesium intake/kg: dietary magnesium intake per kilogram bodyweight; MetS: metabolic syndrome.
Prevalence Ratios (95% CI) for MetS According to Quartiles of Dietary Magnesium Intake per Kilogram Body Weight
| Magnesium Intake/kg (Quartiles) | |||||
|---|---|---|---|---|---|
| 1 (Low) | 2 | 3 | 4 (High) | P* | |
| MetS | 1 | 0.646 (0.567, 0.735) | 0.462 (0.403, 0.529) | 0.313 (0.271, 0.363) | <0.001 |
| Model 1 | 1 | 0.555 (0.483, 0.638) | 0.349 (0.297, 0.404) | 0.171 (0.141, 0.207) | <0.001 |
| Model 2 | 1 | 0.550 (0.479, 0.632) | 0.343 (0.294, 0.400) | 0.168 (0.139, 0.204) | <0.001 |
| Model 3 | 1 | 0.481 (0.417, 0.555) | 0.274 (0.233, 0.322) | 0.105 (0.085, 0.131) | <0.001 |
Notes: Data are expressed as coefficients (95% CI). A logarithmic transformation was used to improve the normality of distribution for dependent variables. *All models were constructed by logistic regression analysis. The adjusted covariates in the models were the same as those listed in Table 2. MetS: metabolic syndrome, Magnesium intake/kg: dietary magnesium intake per kilogram body weight.
Figure 2The role of insulin resistance in the association between dietary magnesium intake and MetS. Zero not included in the 95% CI represents statistical significance. MetS: Metabolic syndrome. Regression a indicated that dietary magnesium intake was negatively associated with HOMA-IR and regression b demonstrated that there was a significant positively association between HOMA-IR and Mets.